In order to support the continued growth of Biomapas, the company has appointed a Director of Human Resources, Monika Lakytė. “We are excited to have Monika as a member of our management team. She shares our values and our focus on future goals, her professional experience in recruitment process and personnel management will endorse our continued growth. People as Monika is the result of highest quality standards in our work,” said Juozas Buitkus, Biomapas COO.
On 29th March 2017 UK submitted the notification of its intention to withdraw from the EU. This means that UK will become a ‘third country’ from 30th March’19. Even though leaving the EU with a deal remains the Government’s top priority, UK drug agency is publishing a series of guidance documents for industry and other stakeholders covering the proposed arrangements for the regulation of medicines, medical devices and clinical trials, if UK leaves EU with no deal.
Biomapas a annoncé récemment avoir reçu de la part du Ministère de l’enseignement supérieur et de la recherche l’accréditation Crédit d’Impôt Recherche (CIR) pour une période de trois ans.
Biomapas has recently announced that it has received Research Tax Credit (Crédit d’Impôt Recherche; CIR) accreditation for a three-year period from the French Ministry of Higher Education and Research.